Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers.
Anne-Lise BienvenuStephane PicotPublished in: Molecules (Basel, Switzerland) (2020)
Confirmatory diagnosis based on specific diagnostic biomarkers will be the basis for the optimal treatment of mycetoma and chromoblastomycosis. It will be part of the global management of NTDs under the umbrella of stewardship activities.
Keyphrases